Susa M - Search Results

1

Cyclin G-associated kinase is necessary for osteosarcoma cell proliferation and receptor trafficking.

Susa M, Choy E, Liu X, Schwab J, Hornicek FJ, Mankin H, Duan Z. Susa M, et al. Mol Cancer Ther. 2010 Dec;9(12):3342-50. doi: 10.1158/1535-7163.MCT-10-0637. Epub 2010 Sep 29. Mol Cancer Ther. 2010. PMID: 20881269

2

Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma.

Susa M, Iyer AK, Ryu K, Hornicek FJ, Mankin H, Amiji MM, Duan Z. Susa M, et al. BMC Cancer. 2009 Nov 16;9:399. doi: 10.1186/1471-2407-9-399. BMC Cancer. 2009. PMID: 19917123 Free PMC article.

3

Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosis.

Ryu K, Choy E, Yang C, Susa M, Hornicek FJ, Mankin H, Duan Z. Ryu K, et al. Among authors: susa m. J Orthop Res. 2010 Jul;28(7):971-8. doi: 10.1002/jor.21088. J Orthop Res. 2010. PMID: 20063378 Free article.

4

Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma.

Duan Z, Ji D, Weinstein EJ, Liu X, Susa M, Choy E, Yang C, Mankin H, Hornicek FJ. Duan Z, et al. Among authors: susa m. Cancer Lett. 2010 Jul 28;293(2):220-9. doi: 10.1016/j.canlet.2010.01.014. Epub 2010 Feb 9. Cancer Lett. 2010. PMID: 20144850

5

Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway.

Ryu K, Susa M, Choy E, Yang C, Hornicek FJ, Mankin HJ, Duan Z. Ryu K, et al. Among authors: susa m. BMC Cancer. 2010 May 10;10:187. doi: 10.1186/1471-2407-10-187. BMC Cancer. 2010. PMID: 20459702 Free PMC article.

6

Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.

Susa M, Iyer AK, Ryu K, Choy E, Hornicek FJ, Mankin H, Milane L, Amiji MM, Duan Z. Susa M, et al. PLoS One. 2010 May 24;5(5):e10764. doi: 10.1371/journal.pone.0010764. PLoS One. 2010. PMID: 20520719 Free PMC article.

7

MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.

Duan Z, Choy E, Harmon D, Liu X, Susa M, Mankin H, Hornicek F. Duan Z, et al. Among authors: susa m. Mol Cancer Ther. 2011 Aug;10(8):1337-45. doi: 10.1158/1535-7163.MCT-11-0096. Epub 2011 Jun 10. Mol Cancer Ther. 2011. PMID: 21666078 Free PMC article.

8

Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay.

Susa M, Choy E, Yang C, Schwab J, Mankin H, Hornicek F, Duan Z. Susa M, et al. J Biomol Screen. 2010 Mar;15(3):287-96. doi: 10.1177/1087057109359422. Epub 2010 Feb 11. J Biomol Screen. 2010. PMID: 20150589

9

Nanoparticles: a promising modality in the treatment of sarcomas.

Susa M, Milane L, Amiji MM, Hornicek FJ, Duan Z. Susa M, et al. Pharm Res. 2011 Feb;28(2):260-72. doi: 10.1007/s11095-010-0173-z. Epub 2010 May 27. Pharm Res. 2011. PMID: 20505985 Review.

10

Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancer.

Guo Y, Nemeth J, O'Brien C, Susa M, Liu X, Zhang Z, Choy E, Mankin H, Hornicek F, Duan Z. Guo Y, et al. Among authors: susa m. Clin Cancer Res. 2010 Dec 1;16(23):5759-69. doi: 10.1158/1078-0432.CCR-10-1095. Epub 2010 Aug 10. Clin Cancer Res. 2010. PMID: 20699329

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters